Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
The XXL trial represents the first prospective validation of “biological downstaging” in liver transplantation (LT) for hepatocellular carcinoma. The aim of this study was to compare the Padua downstaging protocol to the XXL protocol in terms of downstaging failure rates and patient outcome. A total...
Main Authors: | Alessandro Vitale, Federica Scolari, Alessandra Bertacco, Enrico Gringeri, Francesco D’Amico, Domenico Bassi, Francesco Enrico D’Amico, Paolo Angeli, Patrizia Burra, Quirino Lai, Umberto Cillo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2406 |
Similar Items
-
Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes
by: Marcello Di Martino, et al.
Published: (2022-10-01) -
Hepatosellüler karsinomada bridging veya downstaging sonrası karaciğer transplantasyonu ile direkt transplantasyon stratejilerinin sağkalım üzerine etkilerinin karşılaştırılması
by: Tuğsan Ballı, et al.
Published: (2019-12-01) -
The New TNM Staging System for Thyroid Cancer and the Risk of Disease Downstaging
by: Claudio Casella, et al.
Published: (2018-09-01) -
Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study
by: Alessandro Beleù, et al.
Published: (2019-02-01) -
Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features
by: Si-Yuan Wang, et al.
Published: (2023-09-01)